US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US5650173A
(en)
*
|
1993-11-19 |
1997-07-22 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
ES2236700T3
(es)
*
|
1993-11-19 |
2005-07-16 |
Janssen Pharmaceutica N.V. |
1,2-benzazoles microencapsulados.
|
ES2172574T5
(es)
*
|
1993-11-19 |
2012-11-29 |
Alkermes, Inc. |
Preparación de micropartículas biodegradables que contienen un agente biológicamente activo
|
EP0733368A1
(de)
*
|
1995-03-24 |
1996-09-25 |
Eli Lilly And Company |
Granulatformulierungen von Olanzapin
|
FR2748205A1
(fr)
*
|
1996-05-06 |
1997-11-07 |
Debio Rech Pharma Sa |
Compositions pharmaceutiques pour la liberation controlee de principes actifs insolubles
|
US5792477A
(en)
*
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
ATE357218T1
(de)
*
|
1996-05-07 |
2007-04-15 |
Alkermes Inc |
Micropartikel
|
ATE302599T1
(de)
*
|
1996-05-24 |
2005-09-15 |
Angiotech Pharm Inc |
Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
|
EP0839525B1
(de)
*
|
1996-10-31 |
2004-08-04 |
Takeda Chemical Industries, Ltd. |
Zubereitung mit verzögerter Freisetzung
|
IL123716A
(en)
*
|
1997-03-27 |
2001-03-19 |
Akzo Nobel Nv |
Therapeutic combinations of mirtazapine and an antipsychotic agent
|
GB9718986D0
(en)
*
|
1997-09-09 |
1997-11-12 |
Danbiosyst Uk |
Controlled release microsphere delivery system
|
US6854841B1
(en)
*
|
1998-04-17 |
2005-02-15 |
Elesys, Inc. |
Point-of-incidence ink-curing mechanisms for radial printing
|
US6224794B1
(en)
|
1998-05-06 |
2001-05-01 |
Angiotech Pharmaceuticals, Inc. |
Methods for microsphere production
|
GB9817078D0
(en)
*
|
1998-08-05 |
1998-10-07 |
Habib Nagy A |
Device for liver surgery
|
UA66872C2
(uk)
*
|
1998-09-30 |
2004-06-15 |
Елі Ліллі Енд Компані |
Сполука, яка є памоатом оланзапіну або його сольватом, та спосіб лікування психотичних розладів
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
WO2000018374A1
(en)
*
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6194006B1
(en)
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
AU768527B2
(en)
*
|
1999-02-23 |
2003-12-18 |
Angiotech International Ag |
Compositions and methods for improving integrity of compromised body passageways and cavities
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US6495166B1
(en)
|
1999-11-12 |
2002-12-17 |
Alkermes Controlled Therapeutics Inc. |
Apparatus and method for preparing microparticles using in-line solvent extraction
|
US6705757B2
(en)
|
1999-11-12 |
2004-03-16 |
Alkermes Controlled Therapeutics, Inc. Ii |
Method and apparatus for preparing microparticles using in-line solvent extraction
|
US6331317B1
(en)
|
1999-11-12 |
2001-12-18 |
Alkermes Controlled Therapeutics Ii Inc. |
Apparatus and method for preparing microparticles
|
US6599532B2
(en)
*
|
2000-01-13 |
2003-07-29 |
Osmotica Corp. |
Osmotic device containing alprazolam and an antipsychotic agent
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
US7666445B2
(en)
*
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
AU2002233239B2
(en)
*
|
2000-12-13 |
2006-05-11 |
Merckle Gmbh |
Microparticles with an improved release profile and method for the production thereof
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
JP2004535431A
(ja)
*
|
2001-06-22 |
2004-11-25 |
サザン バイオシステムズ, インコーポレイテッド |
ゼロ次長期放出同軸インプラント
|
BR0210722A
(pt)
|
2001-06-29 |
2004-07-20 |
Medgraft Microtech Inc |
Implantes injetáveis biodegradáveis e métodos relacionados de produção e uso
|
EP1275378B1
(de)
|
2001-07-10 |
2009-04-15 |
Canon Kabushiki Kaisha |
Partikel auf Basis von Polyhydroxyalkanoat und Verfahren zu deren Herstellung
|
CA2475092C
(en)
|
2002-02-04 |
2012-05-01 |
Christian F. Wertz |
Nanoparticulate compositions having lysozyme as a surface stabilizer
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
US6699963B2
(en)
*
|
2002-03-18 |
2004-03-02 |
The Procter & Gamble Company |
Grinding process for plastic material and compositions therefrom
|
EP2087882A1
(de)
*
|
2002-03-26 |
2009-08-12 |
Teva Pharmaceutical Industries Ltd. |
Arzneimittelmikropartikel
|
GB0216416D0
(en)
*
|
2002-07-15 |
2002-08-21 |
Novartis Ag |
Organic compounds
|
US20040258757A1
(en)
*
|
2002-07-16 |
2004-12-23 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
WO2004030659A1
(en)
*
|
2002-09-30 |
2004-04-15 |
Acusphere, Inc. |
Sustained release porous microparticles for inhalation
|
US20040121003A1
(en)
*
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
US6962006B2
(en)
*
|
2002-12-19 |
2005-11-08 |
Acusphere, Inc. |
Methods and apparatus for making particles using spray dryer and in-line jet mill
|
EP1595549A4
(de)
*
|
2003-02-19 |
2010-09-22 |
Takeda Pharmaceutical |
Dispergens für zubereitungen mit verzögerter freisetzung
|
JP2004331750A
(ja)
|
2003-05-02 |
2004-11-25 |
Canon Inc |
ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
|
NZ527142A
(en)
*
|
2003-07-23 |
2006-03-31 |
Douglas Pharmaceuticals Ltd |
A stable suspension formulation
|
US6987111B2
(en)
*
|
2003-08-06 |
2006-01-17 |
Alkermes Controlled Therapeutics, Ii |
Aripiprazole, olanzapine and haloperidol pamoate salts
|
JP5306599B2
(ja)
*
|
2004-01-12 |
2013-10-02 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
長期間送達製剤
|
US8329203B2
(en)
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
CN1968700A
(zh)
*
|
2004-04-15 |
2007-05-23 |
阿尔克姆斯有限公司 |
聚合物基的持续释放装置
|
DK1742616T3
(en)
*
|
2004-04-30 |
2015-01-12 |
Abraxis Bioscience Llc |
The microsphere-discharge-system for the prolonged delivery and methods of making and using the same
|
ITMI20042232A1
(it)
*
|
2004-11-19 |
2005-02-19 |
Unihart Corp |
Composizione farmaceutica contenente clozapina
|
EP1838716B1
(de)
|
2005-01-05 |
2011-06-01 |
Eli Lilly And Company |
Olanzapinpamoat-dihydrat
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
MX2008000573A
(es)
*
|
2005-07-18 |
2008-03-14 |
Univ Pennsylvania |
Implantes que contienen farmacos y metodos de uso de los mismos.
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US7811604B1
(en)
*
|
2005-11-14 |
2010-10-12 |
Barr Laboratories, Inc. |
Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
|
KR101200728B1
(ko)
|
2006-08-09 |
2012-11-13 |
인타르시아 세라퓨틱스 인코포레이티드 |
삼투성 전달 시스템 및 피스톤 조립체
|
US7538652B2
(en)
*
|
2006-08-29 |
2009-05-26 |
International Business Machines Corporation |
Electrical component tuned by conductive layer deletion
|
CL2007002851A1
(es)
*
|
2006-10-05 |
2008-01-18 |
M S Panacea Biotec Ltd |
Composicion inyectable que comprende micro o nano -particulas biodegradables que incluyen un agente activo, un polimero biodegardable, un agente para intensificar la viscosidad y excipiente farmaceuticamente aceptables; y procedimientos de preparacion
|
WO2008118712A1
(en)
*
|
2007-03-22 |
2008-10-02 |
Alkermes, Inc. |
Coacervation process
|
AU2008244523B2
(en)
|
2007-04-23 |
2012-02-16 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
MX337286B
(es)
|
2007-05-25 |
2016-02-22 |
Indivior Uk Ltd |
Formulaciones de transferencia sostenida de compuestos de risperidona.
|
US20080317865A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
KR101892745B1
(ko)
|
2007-06-25 |
2018-08-28 |
오쓰까 세이야꾸 가부시키가이샤 |
코어/셀 구조를 가진 미소구
|
US9161943B2
(en)
*
|
2007-12-31 |
2015-10-20 |
Industrial Technology Research Institute |
Sustained release composition and manufacturing method thereof
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
CA2764960C
(en)
|
2009-06-09 |
2017-07-18 |
Neuronano Ab |
Microelectrode and multiple microelectrodes
|
SI2462246T1
(en)
|
2009-09-28 |
2018-01-31 |
Intarcia Therapeutics, Inc. |
Fast-setting and / or cessation of substantially unchanged delivery of the product
|
US8641900B2
(en)
*
|
2009-11-05 |
2014-02-04 |
Taiwan Biotech Co., Ltd |
Method and device for continuously preparing microspheres, and collection unit thereof
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
PT3566696T
(pt)
|
2011-04-25 |
2021-01-11 |
Nanjing Luye Pharmaceutical Co Ltd |
Composição de microesfera para libertação sustentada de risperidona
|
CN103301461B
(zh)
*
|
2012-03-08 |
2018-09-07 |
江苏豪森药业集团有限公司 |
一种长效注射制剂及其制备方法和用途
|
CN115804749A
(zh)
|
2013-03-11 |
2023-03-17 |
度瑞公司 |
包含高粘度液体载体的可注射控制释放组合物
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
KR101738127B1
(ko)
*
|
2014-08-08 |
2017-05-22 |
(주)비씨월드제약 |
약물 함유 서방성 미립자의 제조 방법
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
KR20240042548A
(ko)
|
2015-06-03 |
2024-04-02 |
인타르시아 세라퓨틱스 인코포레이티드 |
임플란트 배치 및 제거 시스템들
|
MA53353A
(fr)
|
2016-05-16 |
2021-06-09 |
Intarcia Therapeutics Inc |
Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
EP3565580B1
(de)
|
2017-01-03 |
2024-03-06 |
i2o Therapeutics, Inc. |
Kontinuierlicher verabreichung von exenatid und co-verabreichung von acetaminophen, ethinylestradiol oder levonorgestrel
|
CN114126592A
(zh)
*
|
2019-07-12 |
2022-03-01 |
G2G生物公司 |
含有利凡斯的明的长效制剂及其制备方法
|
CN111991397B
(zh)
*
|
2020-10-13 |
2021-09-10 |
深圳善康医疗健康产业有限公司 |
一种氟哌噻吨美利曲辛微球及其制备方法
|